| P2093 | author name string | Yoshikawa TT | |
| P2860 | cites work | Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981 | Q24671879 |
| | Carbapenems, a new class of beta-lactam antibiotics. Discovery and development of imipenem/cilastatin | Q28305833 |
| | Fatal aplastic anemia following apparent “dose-related” chloramphenicol toxicity | Q28325676 |
| | Acute interstitial nephritis due to methicillin | Q28327538 |
| | Serial trough and peak amikacin levels in plasma as predictors of nephrotoxicity | Q28359459 |
| | Univariate and multivariate analyses of risk factors predisposing to auditory toxicity in patients receiving aminoglycosides | Q28361967 |
| | In vitro activity of N-formimidoyl thienamycin and other beta-lactam antibiotics against methicillin-resistant Staphylococcus aureus | Q30451373 |
| | Drug therapy. Beta-lactam antibiotics (2). | Q30462187 |
| | Vancomycin- and erythromycin-induced hearing loss in humans | Q30502734 |
| | Safety and effectiveness of ticarcillin plus clavulanate potassium in treatment of lower respiratory tract infections | Q33460702 |
| | Comparative study of piperacillin, ticarcillin, and carbenicillin pharmacokinetics | Q33726819 |
| | Pharmacokinetics of cefoperazone in ambulatory elderly volunteers compared with young adults | Q33741136 |
| | Statewide Study of Chloramphenicol Therapy and Fatal Aplastic Anemia | Q34054266 |
| | Drug therapy: The newer cephalosporins | Q34070585 |
| | Prospective randomised trial of metronidazole versus vancomycin for Clostridium-difficile-associated diarrhoea and colitis | Q34247700 |
| | Pharmacokinetic study of cefuroxime in the elderly | Q34449518 |
| | Cefazolin | Q40963284 |
| | DRGs and the future of surgical practice | Q41407632 |
| | Infectious diseases in the elderly | Q41603743 |
| | Acute confusion in elderly medical patients | Q42078551 |
| | Vancomycin toxicity: a prospective study | Q42228839 |
| | Risk Factors for Nephrotoxicity in Patients Treated with Aminoglycosides | Q42247725 |
| | Absorption and disposition of ampicillin in the elderly | Q42671752 |
| | Pharmacokinetics of moxalactam in elderly subjects | Q42929645 |
| | Ceftriaxone: pharmacokinetics and effect on the intestinal microflora in patients with acute bacterial infections | Q43456582 |
| | Ceftriaxone-associated biliary pseudolithiasis in adults | Q43646973 |
| | Ceftriaxone compared with cefotaxime for serious bacterial infections | Q43715734 |
| | Once-daily therapy with ceftriaxone compared with daily multiple-dose therapy with cefotaxime for serious bacterial infections: a randomized, double-blind study | Q43729963 |
| | Pharmacokinetics of oral ciprofloxacin, 100 mg single dose, in volunteers and elderly patients | Q44104901 |
| | The Effect of Age on Creatinine Clearance in Men: A Cross-sectional and Longitudinal Study | Q44464567 |
| | Incidence of diarrhea and colitis associated with clindamycin therapy | Q44926899 |
| | Single-dose pharmacokinetics of intravenous ampicillin plus sulbactam in healthy elderly and young adult subjects | Q46194222 |
| | Successful treatment of malignant external otitis with oral ciprofloxacin: report of experience with 23 patients | Q46853315 |
| | Intraabdominal infections in the elderly | Q50172442 |
| | Listeria and gram-negative bacillary meningitis in New York City, 1972-1979. Frequent causes of meningitis in adults | Q50216181 |
| | Gram-negative bacillary bacteremia in the elderly: incidence, ecology, etiology, and mortality. | Q51218116 |
| | Community-acquired pneumonia requiring hospitalization. Is it different in the elderly? | Q52660848 |
| | Absorption of chloramphenicol sodium succinate after intramuscular administration in children. | Q53727813 |
| | Antimicrobial susceptibilities of anaerobic bacteria isolated at the Mayo Clinic during 1982 through 1987: comparison with results from 1977 through 1981. | Q54356265 |
| | Comparative study using norfloxacin and amoxycillin in the treatment of complicated urinary tract infections in geriatric patients | Q54475626 |
| | Antibiotic prophylaxis in pacemaker surgery--a prospective study. | Q54483845 |
| | Longitudinal studies on the rate of decline in renal function with age. | Q55061206 |
| | Nosocomial infections in U.S. hospitals, 1975–1976 | Q57274721 |
| | Pharmacokinetics of Ciprofloxacin in the Elderly | Q58005450 |
| | Pharmacokinetics of aztreonam in elderly male volunteers | Q34622283 |
| | Study of the Effects of Ticarcillin on Blood Coagulation and Platelet Function | Q34929207 |
| | Results of a Clinical Trial of Cefoxitin, a New Cephamycin Antibiotic | Q34988187 |
| | Imipenem concentrations in colorectal surgery and impact on the colonic microflora | Q35244314 |
| | Penetration of pefloxacin into bronchial secretions | Q35245057 |
| | Disposition of roxithromycin in patients with normal and severely impaired renal function | Q35249786 |
| | Comparative in vitro activities of piperacillin-tazobactam and ticarcillin-clavulanate | Q35343060 |
| | Treatment of genitourinary tract infections with fluoroquinolones: activity in vitro, pharmacokinetics, and clinical efficacy in urinary tract infections and prostatitis | Q35353352 |
| | Steady-state pharmacokinetics of intravenous and oral ciprofloxacin in elderly patients | Q35359695 |
| | Coagulopathy associated with extended-spectrum cephalosporins in patients with serious infections | Q35536776 |
| | Role of aminoglycoside antibiotics in the treatment of intra-abdominal infection | Q35538285 |
| | Randomized, double-blind comparison of ciprofloxacin and trimethoprim-sulfamethoxazole for complicated urinary tract infections | Q35563727 |
| | Comparative pharmacokinetics and serum inhibitory activity of clindamycin in different dosing regimens | Q35565851 |
| | Disposition of ceftazidime in surgical patients with intra-abdominal infection | Q35565956 |
| | Penetration of cefuroxime into ventricular fluid in cerebrospinal fluid shunt infections | Q35566531 |
| | Pharmacokinetics of ceftazidime in elderly volunteers | Q35572837 |
| | Penetration of aztreonam into cerebrospinal fluid of patients with bacterial meningitis | Q35573375 |
| | Cerebrospinal fluid penetration of imipenem and cilastatin (primaxin) in children with central nervous system infections | Q35649855 |
| | Influence of age on tobramycin pharmacokinetics in patients with normal renal function | Q35671955 |
| | N-formimidoyl thienamycin (MK0787): in vitro activity against anaerobic bacteria | Q35673370 |
| | Intravenous metronidazole for treatment of infections involving anaerobic bacteria | Q35674447 |
| | In vitro activity of ticarcillin against anaerobic bacteria compared with that of carbenicillin and penicillin | Q36459602 |
| | Comparative human oral clinical pharmacology of cefadroxil, cephalexin, and cephradine | Q36459896 |
| | Susceptibility of anaerobic bacteria to cofoxitin and related compounds | Q36463129 |
| | Clinical Pharmacology of Mezlocillin | Q36466089 |
| | Erythromycin: a microbial and clinical perspective after 30 years of clinical use (1). | Q37904600 |
| | Characterization of beta-lactamases | Q38640000 |
| | Reappraisal of the antistaphylococcal activities of first-generation (narrow-spectrum) and second-generation (expanded-spectrum) cephalosporins | Q38640057 |
| | Aminoglycoside-induced hearing loss in humans | Q38676819 |
| | New directions for macrolide antibiotics: structural modifications and in vitro activity | Q38721368 |
| | New directions for macrolide antibiotics: pharmacokinetics and clinical efficacy | Q38721378 |
| | Acute Bacterial Meningitis at Boston City Hospital during 12 Selected Years, 1935-1972 | Q39165549 |
| | Letter: Chloramphenicol eye-drops and marrow aplasia | Q39338781 |
| | Treatment of gram-negative infections in patients with renal impairment: new alternatives to aminoglycosides | Q39558431 |
| | Cefotetan: a review of the microbiologic properties and antimicrobial spectrum | Q39644150 |
| | Immediate hypersensitivity reactions to beta-lactam antibiotics | Q39661271 |
| | Comparative Study of Anti-Pseudomonas Activity of Azlocillin, Mezlocillin, and Ticarcillin | Q39675318 |
| | In vitro study of clavulanic acid in combination with penicillin, amoxycillin, and carbenicillin | Q39725488 |
| | Vancomycin Revisited | Q39736527 |
| | Risk factors and comparisons of clinical nephrotoxicity of aminoglycosides | Q39738110 |
| | Management of intra-abdominal sepsis | Q39738124 |
| | Comparative review of combination therapy: two beta-lactams versus beta-lactam plus aminoglycoside | Q39738131 |
| | Clinical pharmacokinetics of vancomycin | Q39743278 |
| | Review of adverse experiences and tolerability in the first 2,516 patients treated with imipenem/cilastatin | Q39809476 |
| | Effect of age and renal function on cefonicid pharmacokinetics | Q39814883 |
| | Inhibition of norfloxacin absorption by antacids | Q39815512 |
| | Multiple-dose pharmacokinetics of concurrent oral ciprofloxacin and rifampin therapy in elderly patients | Q39815523 |
| | Review of the in vitro spectrum of activity of imipenem | Q39821698 |
| | Cefamandole and cefoxitin | Q39821788 |
| | Imipenem: first of a new class of beta-lactam antibiotics | Q39829062 |
| | Enoxacin penetration into human prostatic tissue | Q39832360 |
| | Pharmacokinetics and human tissue penetration of flurithromycin | Q39832942 |
| | Fever and aging | Q39835205 |
| | In vitro efficacy of sulbactam combined with ampicillin against anaerobic bacteria | Q39849981 |
| | Selected overview of nongynecologic surgical intra-abdominal infections. Prophylaxis and therapy | Q39850192 |
| | Susceptibility of enterococci and Listeria monocytogenes to N-Formimidoyl thienamycin alone and in combination with an aminoglycoside | Q39855023 |
| | Single-dose pharmacokinetics of the monobactam azthreonam (SQ 26,776) in healthy subjects | Q39857251 |
| | Mode of action of azthreonam | Q39857259 |
| | Tuberculosis in the Geriatric Patient | Q40149783 |
| | Chloramphenicol in the 1980s | Q40189646 |
| | Infective endocarditis in the aging patient | Q40189770 |
| | Unique aspects of urinary tract infection in the geriatric population | Q40189785 |
| | Piperacillin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. | Q40196652 |
| | Cefoperazone: A review of its in vitro antimicrobial activity, pharmacological properties and therapeutic efficacy | Q40219455 |
| | The new beta-lactamase-stable cephalosporins | Q40265698 |
| | Mezlocillin pharmacokinetics after single intravenous doses to patients with varying degrees of renal function | Q40281838 |
| | Comparative evaluation of a new beta-lactamase inhibitor, YTR 830, combined with different beta-lactam antibiotics against bacteria harboring known beta-lactamases | Q40283720 |
| | Drug therapy: metronidazole | Q40291727 |
| | Pharmacology and aging | Q40326082 |
| | Drug therapy: drug disposition in old age. | Q40328549 |
| | Pharmacokinetics of cefamandole in patients with normal and impaired renal function | Q40616775 |
| | Combined Activity of Clavulanic Acid and Ticarcillin Against Ticarcillin-Resistant, Gram-Negative Bacilli | Q40618972 |
| | CP-45,899, a Beta-Lactamase Inhibitor That Extends the Antibacterial Spectrum of Beta-Lactams: Initial Bacteriological Characterization | Q40619146 |
| | Clavulanic Acid, a Novel Inhibitor of β-Lactamases | Q40619414 |
| | Utility of fever, white blood cells, and differential count in predicting bacterial infections in the elderly | Q40774409 |
| | Combination therapy and monotherapy in the treatment of severe infection in the immunocompromised host | Q40807163 |
| | Effect of aging on the clinical significance of fever in ambulatory adult patients | Q40828123 |
| | Absorption, Distribution and Elimination of Cefazolin in Patients with Normal Renal Function | Q40909012 |
| | Evaluation of chloramphenicol acid succinate therapy of induced typhoid fever and rocky mountain spotted fever | Q40934712 |
| | Cefuroxime, a New Cephalosporin Antibiotic: Activity In Vitro | Q40946164 |
| | Inactivation of gentamicin by penicillins in patients with renal failure | Q40946710 |
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1353-1372 | |
| P577 | publication date | 1990-12-01 | |
| P1433 | published in | Journal of the American Geriatrics Society | Q6296094 |
| P1476 | title | Antimicrobial therapy for the elderly patient | |
| P478 | volume | 38 | |